Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study
ABVD
Dacarbazine
Stereotactic biopsy
DOI:
10.2967/jnumed.116.184218
Publication Date:
2017-01-27T01:11:00Z
AUTHORS (22)
ABSTRACT
PET/CT-ascertained bone marrow involvement (BMI) constitutes the single most important reason for upstaging by PET/CT in Hodgkin lymphoma (HL). However, BMI assessment can be challenging. This study analyzed clinicopathologic correlations and prognostic meaning of different patterns (BM) <sup>18</sup>F-FDG uptake HL. <b>Methods:</b> One hundred eighty newly diagnosed early unfavorable advanced-stage HL patients, all scanned at baseline after 2 adriamycin-bleomycin-vinblastine-dacarbazine (ABVD) courses with PET, enrolled international studies aimed assessing role interim PET scanning HL, were retrospectively included. Patients treated ABVD × 4–6 cycles involved-field radiation when needed, no treatment adaptation on was allowed. Two masked reviewers independently reported scans. <b>Results:</b> Thirty-eight patients (21.1%) had focal lesions (fPET<sup>+</sup>), 10 them a (unifocal) 28 multiple (multifocal) BM lesions. Fifty-three (29.4%) pure strong (>liver) diffuse (dPET<sup>+</sup>) 89 (48.4%) showed or faint (≤liver) (nPET<sup>+</sup>). biopsy positive 6 38 (15.7%) fPET<sup>+</sup>, 1 53 (1.9%) dPET<sup>+</sup>, 5 (5.6%) nPET<sup>+</sup>. dPET<sup>+</sup> correlated younger age, higher frequency bulky disease, lower hemoglobin levels, leukocyte counts, similar spleen. 3-y progression-free survival identical to without any (82.9% 82.2%, respectively, <i>P</i> = 0.918). fPET+ (either unifocal multifocal) significantly inferior dPET+ nPET+ (66.7% 82.5%, <i>P =</i> 0.03). The κ values interobserver agreement 0.84 0.78 uptake. <b>Conclusion:</b> We confirmed that is reliable tool longer needed routine staging. Moreover, this proved excellent only should considered as harbinger
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (27)
CITATIONS (30)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....